Skip to main content
SpringerLink
Log in

European Paediatric Formulation Initiative (EuPFI)—Formulating Ideas for Better Medicines for Children

  • Mini-Review
  • Theme: Pediatric Drug Development and Dosage Form Design
  • Published:
AAPS PharmSciTech Aims and scope Submit manuscript

Abstract

The European Paediatric Formulation Initiative (EuPFI), founded in 2007, aims to promote and facilitate the preparation of better and safe medicines for children through linking research and information dissemination. It brings together the capabilities of the industry, academics, hospitals, and regulators within a common platform in order to scope the solid understanding of the major issues, which will underpin the progress towards the future of paediatric medicines we want.The EuPFI was formed in parallel to the adoption of regulations within the EU and USA and has served as a community that drives research and dissemination through publications and the organisation of annual conferences. The membership and reach of this group have grown since its inception in 2007 and continue to develop and evolve to meet the continuing needs and ambitions of research into and development of age appropriate medicines. Five diverse workstreams (age-appropriate medicines, Biopharmaceutics, Administration Devices, Excipients and Taste Assessment & Taste Masking (TATM)) direct specific workpackages on behalf of the EuPFI. Furthermore, EuPFI interacts with multiple diverse professional groups across the globe to ensure efficient working in the area of paediatric medicines. Strong commitment and active involvement of all EuPFI stakeholders have proved to be vital to effectively address knowledge gaps related to paediatric medicines, discuss potential areas for further research and identify issues that need more attention and analysis in the future.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. EC. Regulation (EC) No 1901/2006 of the European Parliament and of the Council on medicinal products for paediatric use and amending Regulation (EEC) No 1768/92, Directive 2001/20/EC, Directive 2001/83/EC and Regulation (EC) No 726/2004. Available at: http://eur-lex.europa.eu/eli/reg/2006/1901/oj. 2006.

  2. PREA. Pediatric Research Equity Act, Pub. L. No. 108–155, 117 Stat. 1936, http://www.fda.gov/downloads/Drugs/DevelopmentApprovalProcess/DevelopmentResources/UCM077853.pdf; 2003 Accessed March, 2015. 2003.

  3. Nunn T, Williams J. Formulation of medicines for children. Br J Clin Pharmacol. 2005;59(6):674–6.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Sam T, Ernest TB, Walsh J, Williams JL. A benefit/risk approach towards selecting appropriate pharmaceutical dosage forms—an application for paediatric dosage form selection. Int J Pharm. 2012;435(2):115–23.

    Article  CAS  PubMed  Google Scholar 

  5. Ernest TB, Craig J, Nunn A, Salunke S, Tuleu C, Breitkreutz J, et al. Preparation of medicines for children—a hierarchy of classification. Int J Pharm. 2012;435(2):124–30.

    Article  CAS  PubMed  Google Scholar 

  6. Liu F, Ranmal S, Batchelor HK, Orlu-Gul M, Ernest TB, Thomas IW, et al. Patient-centred pharmaceutical design to improve acceptability of medicines: similarities and differences in paediatric and geriatric populations. Drugs. 2014;74(16):1871–89.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Liu F, Ranmal S, Batchelor HK, Orlu-Gul M, Ernest TB, Thomas IW, et al. Formulation factors affecting acceptability of oral medicines in children. Int J Pharm. 2015;492(1–2):341–3.

    Article  CAS  PubMed  Google Scholar 

  8. Batchelor HK, Kendall R, Desset-Brethes S, Alex R, Ernest TB. Application of in vitro biopharmaceutical methods in development of immediate release oral dosage forms intended for paediatric patients. Eur J Pharm Biopharm: Off J Arbeitsgemeinschaft Pharmazeutische Verfahrenstechnik eV. 2013;85(3 Pt B):833–42.

    Article  CAS  Google Scholar 

  9. Batchelor H. Paediatric biopharmaceutics classification system: current status and future decisions. Int J Pharm. 2014;469(2):251–3.

    Article  CAS  PubMed  Google Scholar 

  10. Batchelor ET, Flanagan T., Klein S., Turner R., Fotaki N., Storey D., Towards the development of a paediatric biopharmaceutics classification system: results of a survey of experts. International Journal of Pharmaceutics. 2016 (in press).

  11. Wachtel H. Regulatory aspects of devices. Int J Pharm. 2012;435(2):142–4.

    Article  PubMed  Google Scholar 

  12. Walsh J, Bickmann D, Breitkreutz J, Chariot-Goulet M. Delivery devices for the administration of paediatric formulations: overview of current practice, challenges and recent developments. Int J Pharm. 2011;415(1–2):221–31.

    Article  CAS  PubMed  Google Scholar 

  13. Walsh J, Math MC, Breitkreutz J, Zerback T, Wachtel H. Devices for oral and respiratory paediatric medicines: what do healthcare professionals think? Int J Pharm. 2015;492(1–2):304–15.

    Article  CAS  PubMed  Google Scholar 

  14. Salunke S, Giacoia G, Tuleu C. The STEP (safety and toxicity of excipients for paediatrics) database. Part 1—a need assessment study. Int J Pharm. 2012;435(2):101–11.

    Article  CAS  PubMed  Google Scholar 

  15. Salunke S, Brandys B, Giacoia G, Tuleu C. The STEP (safety and toxicity of excipients for paediatrics) database: part 2—the pilot version. Int J Pharm. 2013;457(1):310–22.

    Article  CAS  PubMed  Google Scholar 

  16. Salunke S, Tuleu C. The STEP database through the end-users eyes—Usability Study. Int J Pharm. 2015;492(1–2):316–31.

    Article  CAS  PubMed  Google Scholar 

  17. Cram A, Breitkreutz J, Desset-Brèthes S, Nunn T, Tuleu C, European Paediatric Formulation Initiative (EuPFI). Challenges of developing palatable oral paediatric formulations. Int J Pharm. 2009;365(1–2):1–3. doi:10.1016/j.ijpharm.2008.09.015.

  18. Pein M, Gondongwe XD, Habara M, Winzenburg G. Interlaboratory testing of Insent e-tongues. Int J Pharm. 2014;469(2):228–37.

    Article  CAS  PubMed  Google Scholar 

  19. Walsh J, Cram A, Woertz K, Breitkreutz J, Winzenburg G, Turner R, et al. Playing hide and seek with poorly tasting paediatric medicines: do not forget the excipients. Adv Drug Deliv Rev. 2014;73:14–33.

    Article  CAS  PubMed  Google Scholar 

  20. Mohamed-Ahmed AH, Soto J., Ernest T., C Tuleu. Non-human tools for the evaluation of bitter taste in the design and development of medicines: a systematic review. Drug Discovery (accepted for publication). 2016.

  21. Batchelor H, Salunke S, Tuleu C. Formulating better medicines for children-reflections. Int J Pharm. 2015;492(1–2):301–3.

    Article  CAS  PubMed  Google Scholar 

  22. Salunke S, Tuleu C. ‘Formulating better medicines for children’—the leap forward. Int J Pharm. 2014;469(2):225–7.

    Article  CAS  PubMed  Google Scholar 

  23. Salunke S, Tuleu C. ‘Formulating better medicines for children’—setting the pace for the future. Int J Pharm. 2013;457(1):308–9.

    Article  CAS  PubMed  Google Scholar 

  24. Tuleu C. ‘Formulating better medicines for children’—still paving the road. Int J Pharm. 2012;435(2):99–100.

    Article  CAS  PubMed  Google Scholar 

  25. Salunke S, Hempenstall J, Kendall R, Roger B, Mroz C, Nunn T, et al. European Paediatric Formulation Initiative’s (EuPFI) 2nd conference commentary—formulating better medicines for children. Int J Pharm. 2011;419(1–2):235–9.

    Article  CAS  PubMed  Google Scholar 

  26. Walsh J, Mills S. Conference report: formulating better medicines for children: 4th European Paediatric Formulation Initiative conference. Ther Deliv. 2013;4(1):21–5. doi:10.4155/tde.12.135.

    Article  CAS  PubMed  Google Scholar 

  27. Walsh J, Mills S. Conference report: formulating better medicines for children: 4th European Paediatric Formulation Initiative conference. Ther Deliv. 2013;4(1):21–5.

    Article  CAS  PubMed  Google Scholar 

  28. Salunke S, Tuleu C. Formulating better medicines for children-Still too far to walk. Int J Pharm. 2016;S0378–5173(16):30604–4. doi:10.1016/j.ijpharm.2016.06.114.

  29. NICHD. Best Pharmaceuticals for Children Act (BPCA) Pediatric Formulation Initiative (PFI) working meeting December 6–7, 2005 Bethesda, MD. 2005.

  30. SPaeDD. SPaeDD-UK: Smart Paediatric Drug Development. Accessible at : http://www.paediatricscienceuk.com/store/c1/Featured_Products.html. 2015.

Download references

Acknowledgments

The authors acknowledge all the members of EuPFI who provided support for this work and Patricia Fowler for her help in proofreading the manuscript.

Author information

Authors and Affiliations

  1. Department of Pharmaceutics & Centre for Paediatric Pharmacy Research, UCL School of Pharmacy, 29-39 Brunswick Square, London, WC1N 1AX, UK

    Smita Salunke & Catherine Tuleu

  2. Department of Pharmacy, School of Life and Medical Sciences, University of Hertfordshire, Hatfield, AL10 9AB, UK

    Fang Liu

  3. School of Pharmacy, Institute of Clinical Sciences, University of Birmingham, Robert Aitken Building, Edgbaston, Birmingham, B15 2TT, UK

    Hannah Batchelor

  4. Jenny Walsh Consulting Ltd., BioCity Nottingham, Pennyfoot Street, Nottingham, NG1 1GF, UK

    Jenny Walsh

  5. Novartis Pharma AG, Postfach, CH-4002, Basel, Switzerland

    Roy Turner

  6. AbbVie, Department R4P7, Bldg.AP31-4, 1N Waukegan Road, North Chicago, Illinois, 60064, USA

    Tzuchi Rob Ju

Authors
  1. Smita Salunke
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Fang Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hannah Batchelor
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jenny Walsh
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Roy Turner
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Tzuchi Rob Ju
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Catherine Tuleu
    View author publications

    You can also search for this author in PubMed Google Scholar

Consortia

on behalf of European Paediatric Formulation Initiative (EuPFI)

Corresponding author

Correspondence to Smita Salunke.

Additional information

Guest Editors: Maren Preis and Jörg Breitkreutz

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Salunke, S., Liu, F., Batchelor, H. et al. European Paediatric Formulation Initiative (EuPFI)—Formulating Ideas for Better Medicines for Children. AAPS PharmSciTech 18, 257–262 (2017). https://doi.org/10.1208/s12249-016-0584-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1208/s12249-016-0584-1

KEY WORDS

Search

Navigation